Non‐inferior and more feasible transcutaneous tibial nerve stimulation in treating overactive bladder: A systematic review and meta‐analysis

Overactive bladder (OAB) is identified as a urinary urgency accompanied by frequency and nocturia with or without urgency urinary incontinence in the nonexistence of a urinary tract infection or other evident pathologies. This systematic review and meta‐analysis aimed to evaluate the efficacy of the transcutaneous tibial nerve stimulation (TTNS) versus percutaneous tibial nerve stimulation (PTNS) or anticholinergic drugs in reducing symptoms and improving the quality of life for OAB patients.

[1]  N. Yang,et al.  Comparisons of the therapeutic safety of seven oral antimuscarinic drugs in patients with overactive bladder: a network meta-analysis , 2021, The Journal of international medical research.

[2]  I. Ramírez-García,et al.  Patient‐reported outcomes in the setting of a randomized control trial on the efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome , 2020, Neurourology and urodynamics.

[3]  Natalie S Blencowe,et al.  RoB 2: a revised tool for assessing risk of bias in randomised trials , 2019, BMJ.

[4]  M. J. B. C. Girão,et al.  Comparação entre oxibutinina, eletroestimulação do nervo tibial posterior e exercícios perineais no tratamento da síndrome da bexiga hiperativa , 2019, Fisioterapia e Pesquisa.

[5]  NICE Guidance – Urinary incontinence and pelvic organ prolapse in women: management , 2019, BJU international.

[6]  I. Ramírez-García,et al.  Efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome: Randomized control trial , 2018, Neurourology and urodynamics.

[7]  L. Prearo,et al.  Comparison of oxybutynin, electrostimulation of the posterior tibial nerve and perineal exercises in the treatment of overactive bladder syndrome , 2019 .

[8]  M. Martin-Garcia,et al.  A single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in Overactive Bladder symptoms in women responders to percutaneous tibial nerve stimulation (PTNS). , 2019, Physiotherapy.

[9]  C. Knowles,et al.  Feasibility of using a novel non-invasive ambulatory tibial nerve stimulation device for the home-based treatment of overactive bladder symptoms , 2018, Translational andrology and urology.

[10]  P. Bigot,et al.  Transcutaneous tibial nerve stimulation: 2 years follow-up outcomes in the management of anticholinergic refractory overactive bladder , 2018, World Journal of Urology.

[11]  M. Lawrence,et al.  The effectiveness of transcutaneous tibial nerve stimulation (TTNS) for adults with overactive bladder syndrome: A systematic review , 2018, Neurourology and urodynamics.

[12]  Ariel Castro,et al.  Transcutaneous posterior tibial nerve stimulation versus extended release oxybutynin in overactive bladder patients. A prospective randomized trial. , 2016, European journal of obstetrics, gynecology, and reproductive biology.

[13]  H. Rahardjo,et al.  Effectiveness of Short Term Percutaneous Tibial Nerve Stimulation for Non-neurogenic Overactive Bladder Syndrome in Adults: A Meta-analysis. , 2015, Acta medica Indonesiana.

[14]  M. Faraday,et al.  Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. , 2015, The Journal of urology.

[15]  L. Liao,et al.  The possible role of percutaneous tibial nerve stimulation using adhesive skin surface electrodes in patients with neurogenic detrusor overactivity secondary to spinal cord injury , 2015, International Urology and Nephrology.

[16]  A. D. Pozo,et al.  Eficacia de la estimulación percutánea versus transcutánea del nervio tibial posterior en pacientes con vejiga hiperactiva , 2014 .

[17]  L. Reis,et al.  Prospective and randomized comparison of electrical stimulation of the posterior tibial nerve versus oxybutynin versus their combination for treatment of women with overactive bladder syndrome , 2014, World Journal of Urology.

[18]  P. Latthe,et al.  Effectiveness of percutaneous posterior tibial nerve stimulation for overactive bladder: A systematic review and meta‐analysis , 2012, Neurourology and urodynamics.

[19]  K. Coyne,et al.  Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS. , 2012, Urology.

[20]  T. Griebling.  WORLDWIDE PREVALENCE ESTIMATES OF LOWER URINARY TRACT SYMPTOMS, OVERACTIVE BLADDER, URINARY INCONTINENCE, AND BLADDER OUTLET OBSTRUCTION , 2011, BJU international.

[21]  S. Tennstedt,et al.  Beyond incontinence: the stigma of other urinary symptoms. , 2010, Journal of advanced nursing.

[22]  J. Ioannidis,et al.  The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions : Explanation and Elaboration , 2009 .

[23]  J. Ioannidis,et al.  The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, Annals of Internal Medicine [serial online].

[24]  S. Bellamy,et al.  Discontinuation Rates of Anticholinergic Medications Used for the Treatment of Lower Urinary Tract Symptoms , 2008, Obstetrics and gynecology.

[25]  C. Roxburgh,et al.  Anticholinergic drugs versus other medications for overactive bladder syndrome in adults. , 2007, The Cochrane database of systematic reviews.

[26]  B. Parratte,et al.  Urodynamic effect of acute transcutaneous posterior tibial nerve stimulation in overactive bladder. , 2003, The Journal of urology.

[27]  L. Kiemeney,et al.  Posterior tibial nerve stimulation in the treatment of urge incontinence , 2003, Neurourology and urodynamics.